Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Ultra-High Dose i.v. N-acetylcysteine Prevent Contrast Nephropathy in Patients With Chronic Kidney Disease Undergoing Emergency Contrast Tomography.

NCT01467154 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT01467154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01467154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Ultra-High Dose i.v. N-acetylcysteine Prevent Contrast Nephropathy in Patients With Chronic Kidney Disease Undergoing Emergency Contrast Tomography.
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Completed
Start date
May 31, 2008
Completion date
November 30, 2011
Enrollment
124 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotoxicity